Investors
2023 Third quarter announcement
We announced our third quarter 2023 results on Wednesday 1 November. Access our Q3 2023 results and latest Annual Report below.
We’re confident in our future
Our bold ambitions for patients are reflected in our commitments to a step-change in growth and performance over the period to 2026. This means more GSK vaccines and medicines, including innovative new products, will reach more people than ever before.
Speeches and presentations
GSK dividend
GSK share price
Share price tool
Detailed information on GSK's share price, including an interactive chart
Innovation stories
In the face of climate change, vaccines play a crucial but underestimated role
‘Adult vaccination plays an essential role in healthy ageing, so let’s prioritise prevention and make it a new standard of care’
A preventative patient-centred approach is key to transforming respiratory care and relieving struggling services
‘It can get very serious, very quickly’: the symptoms, risks, and ways to prevent pneumonia everyone should know about
'Prevention is the best medicine to stop disease before it starts'
Millions of people living with chronic hepatitis B are unaware they have the virus. So why aren’t they getting diagnosed?
‘You can’t be what you can’t see’: Why diversity in STEM is key to greater medical innovation
‘AI has already transformed medical innovation. Let’s not let fears of technology stop us from realising its incredible potential.’
Biomarker testing is helping doctors find precision treatments for patients that could dramatically improve health outcomes
‘Teenagers may feel invincible – but we’re at high risk’: what you need to know about meningitis as cases see post-Covid pandemic rebound in some countries
